Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723481 | 12772348 | 1 | I | 20160914 | 20160922 | 20160922 | EXP | GB-MYLANLABS-2016M1039679 | MYLAN | 0.00 | Y | 0.00000 | 20160922 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723481 | 12772348 | 1 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Oral | 300 MG, UNK | U | U | UNKNOWN | 204002 | 300 | MG | |||||
| 127723481 | 12772348 | 2 | SS | NORVIR | RITONAVIR | 1 | Oral | 100 MG, UNK | U | U | UNKNOWN | 0 | 100 | MG | |||||
| 127723481 | 12772348 | 3 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 800 MG, UNK | U | U | UNKNOWN | 0 | 800 | MG | |||||
| 127723481 | 12772348 | 4 | SS | RALTEGRAVIR. | RALTEGRAVIR | 1 | Oral | 400 MG, UNK | U | U | UNKNOWN | 0 | 400 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127723481 | 12772348 | 1 | HIV infection |
| 127723481 | 12772348 | 2 | HIV infection |
| 127723481 | 12772348 | 3 | HIV infection |
| 127723481 | 12772348 | 4 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127723481 | 12772348 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127723481 | 12772348 | Skin ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |